The global landscape for DNA repair therapeutics is evolving rapidly as pharmaceutical companies intensify research efforts in precision oncology and targeted medicine. Rising cancer prevalence, increasing investments in genomic medicine, and advancements in biomarker-driven therapies are contributing to strong industry expansion across developed and emerging economies. Growing awareness...

The new market report titled ‘PARP Inhibitors Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the PARP Inhibitors Market.   The PARP inhibitors market is estimated to be worth $8 billion in 2030 and is expected to grow at CAGR of 18% during the forecast period. The report will help readers stay updated with the latest...